Pulmonary embolism caused by thrombin-based haemostatic matrix

BMJ Case Rep. 2017 Dec 7:2017:bcr2017223503. doi: 10.1136/bcr-2017-223503.

Authors

Ala-Eddin S Sagar¹, Erik Vakil², Carlos A Jimenez², Reeba Mathew¹

Affiliations

¹ Pulmonary, Critical Care and Sleep Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
² Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

No abstract available

Keywords: pulmonary embolism; radiology.

Publication types

Case Reports

MeSH terms

Adult
Ambulatory Surgical Procedures
Anticoagulants / therapeutic use
Blood Loss, Surgical / prevention & control*
Chest Pain
Computed Tomography Angiography
Diskectomy / adverse effects*
Dyspnea
Female
Hemostasis
Hemostatics / administration & dosage
Hemostatics / adverse effects*
Heparin / therapeutic use
Humans
Postoperative Complications / chemically induced
Postoperative Complications / diagnostic imaging*
Postoperative Complications / drug therapy
Pulmonary Embolism / chemically induced
Pulmonary Embolism / diagnostic imaging*
Pulmonary Embolism / drug therapy
Thrombin / administration & dosage
Thrombin / adverse effects*
Treatment Outcome
Ultrasonography, Doppler, Duplex

Substances

Anticoagulants
Hemostatics
Heparin
Thrombin